AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1625-H1631, 2004. First published June 10, 2004; doi:10.1152/ajpheart.00298.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/4/H1625    most recent
00298.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, K. L.
Right arrow Articles by Wu, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, K. L.
Right arrow Articles by Wu, Q.

Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium

Katherine L. Tran,1 Xiangru Lu,2 Ming Lei,2 Qingping Feng,2 and Qingyu Wu1

1Department of Cardiovascular Research, Berlex Biosciences, Richmond, California 94804; and 2Department of Medicine, Physiology and Pharmacology, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada N6A 4G5

Submitted 29 March 2004 ; accepted in final form 20 May 2004

High levels of plasma atrial natriuretic peptides (ANP) are associated with pathological conditions such as congestive heart failure (CHF). Recently, we have identified a cardiac serine protease, corin, that is the pro-ANP convertase. In this study, we examined the regulation of corin gene expression in cultured hypertrophic cardiomyocytes and in the left ventricular (LV) myocardium of a rat model of heart failure. Quantitative RT-PCR analysis showed that both corin and ANP mRNA levels were significantly increased in phenylephrine (PE)-stimulated rat neonatal cardiomyocytes in culture. The increase in corin mRNA correlated closely with the increase in cell size and ANP mRNA expression in the PE-treated cells (r = 0.95, P < 0.01; r = 0.92, P < 0.01, respectively). The PE-treated cardiomyocytes had an increased activity in converting recombinant human pro-ANP to biologically active ANP, as determined by a pro-ANP processing assay and a cell-based cGMP assay. In a rat model of heart failure induced by ligation of the left coronary artery, corin mRNA expression in the noninfarcted LV myocardium was significantly higher than that of control heart tissues from sham-operated animals, when examined by Northern blot analysis and RT-PCR at 8 wk. These results indicate that the corin gene is upregulated in hypertrophic cardiomyocytes and failing myocardium. Increased corin expression may contribute to elevation of ANP in the setting of cardiac hypertrophy and heart failure.

congestive heart failure; atrial natriuretic peptide; brain natriuretic peptide; serine protease



Address for reprint requests and other correspondence: Q. Wu, Berlex Biosciences, 2600 Hilltop Dr., Richmond, CA 94804 (E-mail: qywu88{at}yahoo.com)




This article has been cited by other articles:


Home page
HypertensionHome page
D. L. Dries
Relevance of Molecular Forms of Brain Natriuretic Peptide for Natriuretic Peptide Research
Hypertension, May 1, 2007; 49(5): 971 - 973.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.